A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer
Publication
, Conference
Halabi, S; Lin, CY; Kelly, WK; Fizazi, K; Moul, JW; Kaplan, E; Morris, MJ; Small, EJ
Published in: EUROPEAN JOURNAL OF CANCER
September 1, 2013
Duke Scholars
Published In
EUROPEAN JOURNAL OF CANCER
EISSN
1879-0852
ISSN
0959-8049
Publication Date
September 1, 2013
Volume
49
Start / End Page
S679 / S679
Location
Amsterdam, NETHERLANDS
Publisher
ELSEVIER SCI LTD
Conference Name
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Halabi, S., Lin, C. Y., Kelly, W. K., Fizazi, K., Moul, J. W., Kaplan, E., … Small, E. J. (2013). A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer. In EUROPEAN JOURNAL OF CANCER (Vol. 49, pp. S679–S679). Amsterdam, NETHERLANDS: ELSEVIER SCI LTD.
Halabi, S., C. Y. Lin, W. K. Kelly, K. Fizazi, J. W. Moul, E. Kaplan, M. J. Morris, and E. J. Small. “A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer.” In EUROPEAN JOURNAL OF CANCER, 49:S679–S679. ELSEVIER SCI LTD, 2013.
Halabi S, Lin CY, Kelly WK, Fizazi K, Moul JW, Kaplan E, et al. A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer. In: EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD; 2013. p. S679–S679.
Halabi, S., et al. “A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer.” EUROPEAN JOURNAL OF CANCER, vol. 49, ELSEVIER SCI LTD, 2013, pp. S679–S679.
Halabi S, Lin CY, Kelly WK, Fizazi K, Moul JW, Kaplan E, Morris MJ, Small EJ. A validated prognostic model for predicting overall survival in patients with metastatic chemotherapy naive castrate-resistant prostate cancer. EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD; 2013. p. S679–S679.
Published In
EUROPEAN JOURNAL OF CANCER
EISSN
1879-0852
ISSN
0959-8049
Publication Date
September 1, 2013
Volume
49
Start / End Page
S679 / S679
Location
Amsterdam, NETHERLANDS
Publisher
ELSEVIER SCI LTD
Conference Name
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis